MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
EXEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Exelixis (EXEL) Ownership - Who owns Exelixis?

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
4600
Web
https://www.exelixis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.21B
P/E Ratio
17.41
Total Cash
777.21M
Projected Growth
2.62
Total Debt
169.54M
Revenue
2.38B
Risk (Beta)
0.31
Dividend Yield
N/A
Total Cash/Share
3.09
Total Debt/Equity
479.87
Revenue/Share
8.59 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
EXEL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for EXEL
A.I. Advisor
published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
4600
Web
https://www.exelixis.com